Scilex Holding Company Increase Decrease In Operating Lease Liability
Scilex Holding Company (SCLX) reported Increase Decrease In Operating Lease Liability of $508.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-14
- Scilex Holding Company increase decrease in operating lease liability for fiscal 2025 was -$857.00K.
- Scilex Holding Company increase decrease in operating lease liability for fiscal 2024 was -$758.00K.
- Scilex Holding Company increase decrease in operating lease liability for fiscal 2023 was -$711.00K.
| Period end | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|
| 2026-06-30 | $508.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | -$857.00K 10-K · filed 2026-04-10 | |
| 2025-06-30 | -$343.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | -$758.00K 10-K · filed 2026-04-10 | |
| 2023-12-31 | -$711.00K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |